Global Information
회사소개 | 문의 | 비교리스트

세계의 뎅기열 백신 시장(2021-2025년)

Global Dengue Vaccine Market 2021-2025

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2021년 05월 상품코드 1010177
페이지 정보 영문 120 Pages 배송안내
가격
US $ 2,500 ₩ 3,551,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 5,682,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 뎅기열 백신 시장(2021-2025년) Global Dengue Vaccine Market 2021-2025
발행일 : 2021년 05월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 뎅기열 백신 시장 규모는 2021-2025년간 1억 3,290만 달러 성장하고, 예측기간 중 18%의 CAGR로 성장할 전망입니다.

시장은 급속한 질병 만연, 효과 없는 뎅기열 대책에 의해 추진되고 있습니다.

세계 뎅기열 백신(Dengue Vaccine) 시장의 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제 및 약 25개 벤더를 커버하는 분석을 제공합니다.

목차

  • 주요 요약
    • 시장 개요
  • 시장 상황
    • 시장 생태계
    • 밸류체인 분석
  • 시장 규모
    • 시장 정의
    • 시장 부문 분석
    • 2020년 시장 규모
    • 시장 전망 : 2020-2025년 예측
  • Five Forces 분석
    • Five Forces 분석
    • 구매자의 협상력
    • 공급 기업의 협상력
    • 신규 참여업체의 위협
    • 대체품의 위협
    • 경쟁의 위협
    • 시장 상황
  • 시장 세분화 : 최종사용자별
    • 시장 부문
    • 최종사용자별 비교
    • 정부기관 : 시장 규모와 예측(2020-2025년)
    • 병원 : 시장 규모와 예측(2020-2025년)
    • NGO : 시장 규모와 예측(2020-2025년)
    • 최종사용자별 시장 기회
  • 고객 상황
  • 지역별 상황
    • 지역별 세분화
    • 지역별 비교
    • 북미 : 시장 규모와 예측(2020-2025년)
    • 아시아 : 시장 규모와 예측(2020-2025년)
    • 유럽 : 시장 규모와 예측(2020-2025년)
    • 기타 지역 : 시장 규모와 예측(2020-2025년)
    • 주요 국가
    • 지역의 시장 기회
    • 시장 추진력
    • 시장 과제
    • 시장 동향
  • 벤더 상황
    • 벤더 상황
    • 경쟁 시나리오
    • 창조적 파괴 상황
  • 벤더 분석
    • 대상 벤더
    • 벤더의 시장 포지셔닝
    • BioNet-Asia Co. Ltd.
    • Chula VRC
    • Codagenix Inc.
    • Emergex Vaccines Holding Ltd.
    • GeneOne Life Science Inc.
    • Imutex Ltd.
    • KM Biologics Co. Ltd.
    • Medigen Biotechnology Corp.
    • Najit Technologies Inc.
    • Sanofi SA
  • 부록
    • 조사 범위
    • 달러 통화 환산율
    • 조사 방법
    • 약어 리스트
KSM 21.06.28

Technavio has been monitoring the dengue vaccine market and it is poised to grow by $ 132.90 million during 2021-2025, progressing at a CAGR of about 18% during the forecast period. Our report on the dengue vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rapid growth in disease prevalence and ineffective dengue control measures. In addition, rapid growth in disease prevalence is anticipated to boost the growth of the market as well.

The dengue vaccine market analysis includes the end-user segment and geographic landscape.

Technavio's dengue vaccine market is segmented as below:

By End-user

  • Government institutions
  • Hospitals
  • NGOs

By Geographical Landscape

  • North America
  • Asia
  • Europe
  • ROW

This study identifies the initiatives for dengue vaccine research and dengue immunization programs as one of the prime reasons driving the dengue vaccine market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on dengue vaccine market covers the following areas:

  • Dengue vaccine market sizing
  • Dengue vaccine market forecast
  • Dengue vaccine market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dengue vaccine market vendors that include BioNet-Asia Co. Ltd., Chula VRC, Codagenix Inc., GeneOne Life Science Inc., Imutex Ltd., KM Biologics Co. Ltd., Medigen Biotechnology Corp., Najit Technologies Inc., Sanofi SA, and Emergex Vaccines Holding Ltd. Also, the dengue vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by End-user
    • Market segments
    • Comparison by End-user
    • Government institutions - Market size and forecast 2020-2025
    • Hospitals - Market size and forecast 2020-2025
    • NGOs - Market size and forecast 2020-2025
    • Market opportunity by End-user
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Vendor landscape
    • Competitive Scenario
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • BioNet-Asia Co. Ltd.
    • Chula VRC
    • Codagenix Inc.
    • Emergex Vaccines Holding Ltd.
    • GeneOne Life Science Inc.
    • Imutex Ltd.
    • KM Biologics Co. Ltd.
    • Medigen Biotechnology Corp.
    • Najit Technologies Inc.
    • Sanofi SA
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: End user - Market share 2020-2025 (%)
  • 22: Comparison by End user
  • 23: Government institutions - Market size and forecast 2020-2025 ($ million)
  • 24: Government institutions - Year-over-year growth 2020-2025 (%)
  • 25: Hospitals - Market size and forecast 2020-2025 ($ million)
  • 26: Hospitals - Year-over-year growth 2020-2025 (%)
  • 27: NGOs - Market size and forecast 2020-2025 ($ million)
  • 28: NGOs - Year-over-year growth 2020-2025 (%)
  • 29: Market opportunity by End user
  • 30: Customer landscape
  • 31: Market share by geography 2020-2025 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2020-2025 ($ million)
  • 34: North America - Year-over-year growth 2020-2025 (%)
  • 35: Asia - Market size and forecast 2020-2025 ($ million)
  • 36: Asia - Year-over-year growth 2020-2025 (%)
  • 37: Europe - Market size and forecast 2020-2025 ($ million)
  • 38: Europe - Year-over-year growth 2020-2025 (%)
  • 39: ROW - Market size and forecast 2020-2025 ($ million)
  • 40: ROW - Year-over-year growth 2020-2025 (%)
  • 41: Key leading countries
  • 42: Market opportunity by geography ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: BioNet-Asia Co. Ltd. - Overview
  • 50: BioNet-Asia Co. Ltd. - Product and service
  • 51: BioNet-Asia Co. Ltd. - Key offerings
  • 52: BioNet-Asia Co. Ltd. - Key customers
  • 53: BioNet-Asia Co. Ltd. - Segment focus
  • 54: Chula VRC - Overview
  • 55: Chula VRC - Product and service
  • 56: Chula VRC - Key offerings
  • 57: Chula VRC - Key customers
  • 58: Chula VRC - Segment focus
  • 59: Codagenix Inc. - Overview
  • 60: Codagenix Inc. - Product and service
  • 61: Codagenix Inc. - Key offerings
  • 62: Codagenix Inc. - Key customers
  • 63: Codagenix Inc. - Segment focus
  • 64: Emergex Vaccines Holding Ltd. - Overview
  • 65: Emergex Vaccines Holding Ltd. - Product and service
  • 66: Emergex Vaccines Holding Ltd. - Key offerings
  • 67: Emergex Vaccines Holding Ltd. - Key customers
  • 68: Emergex Vaccines Holding Ltd. - Segment focus
  • 69: GeneOne Life Science Inc. - Overview
  • 70: GeneOne Life Science Inc. - Product and service
  • 71: GeneOne Life Science Inc. - Key offerings
  • 72: GeneOne Life Science Inc. - Key customers
  • 73: GeneOne Life Science Inc. - Segment focus
  • 74: Imutex Ltd. - Overview
  • 75: Imutex Ltd. - Product and service
  • 76: Imutex Ltd. - Key offerings
  • 77: Imutex Ltd. - Key customers
  • 78: Imutex Ltd. - Segment focus
  • 79: KM Biologics Co. Ltd. - Overview
  • 80: KM Biologics Co. Ltd. - Product and service
  • 81: KM Biologics Co. Ltd. - Key offerings
  • 82: KM Biologics Co. Ltd. - Key customers
  • 83: KM Biologics Co. Ltd. - Segment focus
  • 84: Medigen Biotechnology Corp. - Overview
  • 85: Medigen Biotechnology Corp. - Product and service
  • 86: Medigen Biotechnology Corp. - Key offerings
  • 87: Medigen Biotechnology Corp. - Key customers
  • 88: Medigen Biotechnology Corp. - Segment focus
  • 89: Najit Technologies Inc. - Overview
  • 90: Najit Technologies Inc. - Product and service
  • 91: Najit Technologies Inc. - Key offerings
  • 92: Najit Technologies Inc. - Key customers
  • 93: Najit Technologies Inc. - Segment focus
  • 94: Sanofi SA - Overview
  • 95: Sanofi SA - Business segments
  • 96: Sanofi SA - Key offerings
  • 97: Sanofi SA - Key customers
  • 98: Sanofi SA - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations
Back to Top
전화 문의
F A Q